RSS Feeds

Other News Releases in Health Care & Hospitals

Product Innovators Launch Unique Sensory Tool for Special Needs Youth

CVS/pharmacy Begins Free Health Screenings in Communities Nationwide Through 'A Su Salud' Program

TeamStaff Names Zachary Parker As New Chief Executive Officer

Other News Releases in Trade Show News

Watch Out Wall Street, Toy Fair Gets A Bailout: 'BAILOUT! THE GAME'

DuPont Expects Strong 2010 Agriculture & Nutrition Sales Growth, Margin Expansion

Invitation to the Tirol in the Austria House in Whistler Mountain

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

See more news releases in: Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Pharmaceuticals, Supplementary Medicine, Trade Show News

Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference

HOUSTON, Nov. 20 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that Dan Moore, President and Chief Executive Officer, and Greg Browne, Chief Financial Officer, will present at the 21st Annual Piper Jaffray Health Care Conference in New York on Wednesday, December 2, 2009 at 12:00 PM EST. The conference session and webcast will be audio only and no formal slides will be presented. Piper Jaffray will host a webcast of the presentation live and by replay at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=CYBX&item_id=2539592. The conference webcast replay will be available for 30 days following the conference. The conference webcast can also be accessed at www.cyberonics.com by clicking on the link for this webcast. Access to the webcast is not password protected.

About Cyberonics, Inc. and VNS Therapy(TM)

Cyberonics, Inc. (Nasdaq: CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the treatments of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics, Inc. and VNS Therapy(TM) is available at www.cyberonics.com and www.vnstherapy.com.

    CONTACT INFORMATION:
    Greg Browne, CFO
    Cyberonics, Inc.
    100 Cyberonics Blvd.
    Houston, TX 77058
    Main:  (281) 228-7262
    Fax:  (281) 218-9332
    ir@cyberonics.com

SOURCE Cyberonics, Inc.

RSS Feeds